Covington Wins Six LMG Life Sciences Awards

Covington Wins Six LMG Life Sciences Awards

9/27/2013

NEW YORK, September 27, 2013 — Covington & Burling received six awards at the inaugural LMG Life Sciences awards on September 25, including “FDA Pharmaceutical Firm of the Year” and Richard Kingham’s induction to the Hall of Fame.

The awards, which are selected based on a survey of peers and leading companies in the life sciences industry, “recognize and honor the leading attorneys, firms and in-house counsel teams, which have played a significant role in the life sciences industry over the past year.”

Covington received the following awards:

• Hall of Fame Inductee, Richard Kingham
• Corporate Advisory Attorney of the Year, John Hurvitz
• FDA Pharmaceutical Firm of the Year
• Product Liability Impact Case of the Year - BP uncapped oil spill settlement
• Product Liability Impact Case of the Year - Pfizer Chantix litigations
• Venture Capital Impact Deal of the Year - Moderna Therapeutics (Licensing deal with AstraZeneca) by Flagship Ventures

The firm and its lawyers were shortlisted in 17 categories:

• Antitrust Firm of the Year
• Finance & Transactional Firm of the Year
• Government Investigation (International) Firm of the Year
• Government Investigation (False Claims Act) Firm of the Year
• Healthcare Pricing and Reimbursement Firm of the Year
• FDA Medical Device Firm of the Year
• Licensing & Collaboration Firm of the Year
• Life Cycle Firm of the Year
• Litigation Firm of the Year
• Mergers & Acquisitions Firm of the Year
• Regulatory Firm of the Year
• FDA Pharmaceutical Attorney of the Year, Richard Kingham and Gerald Masoudi
• Finance & Transactional Attorney of the Year, John Hurvitz
• Hatch-Waxman (Branded) Litigator of the Year, George Pappas
• Mergers & Acquisitions Attorney of the Year, John Hurvitz
• Product Liability Attorney of the Year, Mike Brock
• Venture Capital Attorney of the Year, Bruce Deming

LMG is a part of Euromoney Institutional Investor PLC, which publishes Benchmark: Litigation, Managing Intellectual Property and International Financial Law Review (IFLR).

Covington is widely recognized as a leading life sciences international law firm with rankings in Chambers Global, Chambers UK, Chambers USA, Chambers Asia, Legal 500 UK, Legal 500 EMEA, Legal 500 USA and PLC.